Taysha Gene Therapies
TSHA
TSHA
125 hedge funds and large institutions have $232M invested in Taysha Gene Therapies in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-4
Holders Change %
-3.1%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
22
Increased
38
Reduced
31
Closed
25
Calls
$144K
Puts
$7K
Net Calls
+$137K
Net Calls Change
-$32K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$14.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.35M |
| 3 |
Millennium Management
New York
|
+$2.25M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.24M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$1.05M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.65M |
| 2 |
VA
VR Adviser
New York
|
-$5.58M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.5M |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.28M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.53M |
